These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Pharmacological characterizations of recombinant human 5-HT1D alpha and 5-HT1D beta receptor subtypes coupled to adenylate cyclase inhibition in clonal cell lines: apparent differences in drug intrinsic efficacies between human 5-HT1D subtypes. Zgombick JM, Schechter LE, Adham N, Kucharewicz SA, Weinshank RL, Branchek TA. Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):226-36. PubMed ID: 8878051 [Abstract] [Full Text] [Related]
10. Selective antagonism of human 5-HT1D and 5-HT1B receptor-mediated responses in stably transfected C6-glial cells by ketanserin and GR 127,935. Pauwels PJ, Colpaert FC. Eur J Pharmacol; 1996 Apr 04; 300(1-2):141-5. PubMed ID: 8741180 [Abstract] [Full Text] [Related]
11. Ketanserin-sensitive depressant actions of 5-HT receptor agonists in the neonatal rat spinal cord. Manuel NA, Wallis DI, Crick H. Br J Pharmacol; 1995 Nov 04; 116(6):2647-54. PubMed ID: 8590984 [Abstract] [Full Text] [Related]
13. Functional effects of the 5-HT1D receptor antagonist GR 127,935 at human 5-HT1D alpha, 5-HT1D beta, 5-HT1A and opossum 5-HT1B receptors. Pauwels PJ, Palmier C. Eur J Pharmacol; 1995 Jul 18; 290(2):95-103. PubMed ID: 8575538 [Abstract] [Full Text] [Related]
16. 5-Hydroxytryptamine (5-HT)-induced endothelium-dependent relaxation of pig coronary arteries is mediated by 5-HT receptors similar to the 5-HT1D receptor subtype. Schoeffter P, Hoyer D. J Pharmacol Exp Ther; 1990 Jan 18; 252(1):387-95. PubMed ID: 2137176 [Abstract] [Full Text] [Related]
19. Activation of recombinant h 5-HT1B and h 5-HT1D receptors stably expressed in C6 glioma cells produces increases in Ca2+-dependent K+ current. Le Grand B, Panissié A, Pauwels PJ, John GW. Naunyn Schmiedebergs Arch Pharmacol; 1998 Dec 18; 358(6):608-15. PubMed ID: 9879718 [Abstract] [Full Text] [Related]